Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

PharmaBase module will enable recording of NMS data

By News team

Pharmacists will soon be able to maintain records for patients who take advantage of the new medicine service via a module on the Pharmaceutical Services Negotiating Committee’s PharmaBase system.

The PSNC plans to launch a module to support patient data collection and record-keeping requirements of the NMS.

It is also producing a worksheet to enable pharmacists to capture patient information on paper. Patient medication record system suppliers might also look to provide their own systems to support the NMS, according to Alastair Buxton, head of NHS services at the PSNC.

Funding for the development of PharmaBase comes from the levy charged to local pharmaceutical committees and the new module will be provided free of charge, Mr Buxton explained.

The module will include functionality for patient recruitment and data capture, as well as an interview schedule and printable GP feedback form. The system will also collate information on the number of services delivered and generate quarterly reports on the service for primary care trusts.

Mr Buxton revealed that pharmacies will not be required to send NMS data to PCTs on a regular basis. However, he warned that pharmacies should expect random checks from PCTs and will be required to produce reports on request.

Commenting on targeted medicines use reviews, Mr Buxton told The Journal that more clinical conditions will be added to the national target groups at the start of the next financial year (2012–13), with the proportion of MURs that must be delivered to the target groups expected to increase from the recently announced 50 per cent requirement (PJ, 6/13 August 2011, p147).

Citation: The Pharmaceutical Journal URI: 11081807

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Alastair Buxton

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.